Hypoxanthine-guanine phosphoribosyltransferase (HGPRTase), which is a key enzyme in the purine-salvage pathway, catalyzes the synthesis of IMP or GMP from -d-phosphoribosyl-1-pyrophosphate and hypoxanthine or guanine, respectively. Structures of HGPRTase from Thermus thermophilus HB8 in the unliganded form, in complex with IMP and in complex with GMP have been determined at 2.1, 1.9 and 2.2 Å resolution, respectively. The overall fold of the IMP complex was similar to that of the unliganded form, but the main-chain and side-chain atoms of the active site moved to accommodate IMP. The overall folds of the IMP and GMP complexes were almost identical to each other. Structural comparison of the T. thermophilus HB8 enzyme with 6-oxopurine PRTases for which structures have been determined showed that these enzymes can be tentatively divided into groups I and II and that the T. thermophilus HB8 enzyme belongs to group I. The group II enzymes are characterized by an N-terminal extension with additional secondary elements and a long loop connecting the second -helix and -strand compared with the group I enzymes.
Introduction
Purine nucleotides are of central importance to the biosynthesis of DNA, RNA and several cofactors such as ATP and FAD. There are two interrelated pathways for the synthesis of purine nucleotides: the de novo and salvage pathways. Hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) is a key enzyme in the purine-salvage pathway and reversibly catalyzes the transfer of the 5-phophoribosyl group from -d-phosphoribosyl-1-pyrophosphate (PRPP) to hypoxanthine or guanine to form inosine 5 0 -monophosphate (IMP) or guanosine 5 0 -monophosphate (GMP), respectively ( Fig. 1) . HGPRTase deficiency is responsible for Lesch-Nyhan syndrome in humans (Lesch & Nyhan, 1964) . Most protozoan parasites are deficient in the de novo purine-biosynthesis pathway. Therefore, HGPRTase involved in the salvage pathway is a potential target for the development of antiparasitic agents (Wang, 1984; Ullman & Carter, 1995) .
To date, the structures of 6-oxopurine PRTases from Homo sapiens (Eads et al., 1994; Keough et al., 2005) , Toxoplasma gondii (Schumacher et al., 1996; Hé roux et al., 2000) , Tritrichomonas foetus (Somoza et al., 1996) , Trypanosoma cruzi Canyuk et al., 2001) , Plasmodium falciparum (Shi, Li, Tyler, Furneaux, Cahill et al., 1999) , Escherichia coli (Guddat et al., 2002) , Thermoanaerobacter tengcongensis (Chen et al., 2005) and Leishmania tarentolae (Monzani et al., 2007) have been reported in order to elucidate the structurefunction relationship of 6-oxopurine PRTases. These structures show a common / fold and four flexible loops (loops I-IV). The loops are highly mobile and change their conformations depending on the binding of inhibitors, substrates or products. To elucidate the overall and the active-site structure and the enzyme-IMP or enzyme-GMP interactions, we determined the crystal structures of HGPRTase from Thermus thermophilus HB8 (TtHGPRTase) in the unliganded form, of TtHGPRTase complexed with IMP and of TtHGPRTase complexed with GMP. Structural comparison of TtHGPRTase with the related 6-oxopurine PRTases provided some insight into the classification of these enzymes.
Materials and methods

Reagents
Guanine, hypoxanthine, xanthine, GMP, IMP, XMP, 5 0 -phosphoribosyl-1 0 -pyrophosphate (PRPP), dibutylamine and formic acid were obtained from Sigma-Aldrich Inc. (St Louis, USA). Acetonitrile (LC/ MS grade) was purchased from Wako Co. (Osaka, Japan). All reagents were of the highest grade commercially available.
Protein expression and purification
The TTHA0220 gene was amplified by PCR using T. thermophilus HB8 genomic DNA as the template. The amplified fragment was cloned under the control of the T7 promoter of the E. coli expression vector pET-11a (Novagen, Madison, Wisconsin, USA). The expression vector was introduced into E. coli BL21 (DE3) strain (Novagen) and the recombinant strain was cultured in 6 l LB medium supplemented with 50 mg ml À1 ampicillin. The collected cells (19.0 g) were suspended in 20 mM Tris-HCl buffer pH 8.0 containing 50 mM NaCl and disrupted by sonication. The cell lysate was incubated at 343 K for 10 min and kept on ice for 12 min. After ultracentrifugation at 200 000g and 277 K, the soluble fraction was applied onto a Resource ISO column (GE Healthcare, UK) equilibrated with 50 mM sodium phosphate buffer pH 7.0 containing 1.5 M ammonium sulfate and was eluted with a linear gradient of 1.5-0 M ammonium sulfate. TtHGPRTase fractions were applied onto a Resource Q column (Amersham Biosciences) equilibrated with 20 mM Tris-HCl pH 8.0, which was eluted with a linear gradient of 0-0.5 M NaCl. The fractions containing TtHGPRTase were applied onto a hydroxyapatite CHT10-I (Bio-Rad) column equilibrated with 0.01 M sodium phosphate buffer pH 7.0 containing 150 mM NaCl and eluted with a linear gradient of 0.01-0.5 M sodium phosphate buffer containing 150 mM NaCl. The collected TtHGPRTase fractions were applied onto a HiLoad 16/60 Superdex 75 column (GE Healthcare, UK) equilibrated with 20 mM Tris-HCl pH 8.0 containing 150 mM NaCl. The protein solution was desalted on a HiPrep 26/10 desalting column (GE Healthcare, UK) and concentrated to 10.3 mg ml À1 . The protein concentration was estimated from the UV absorption at 260 nm. The overall yield was estimated to be 19 mg from 6 l of culture.
Enzyme assays
The enzyme activity was measured at various concentrations of guanine, hypoxanthine or xanthine in the presence of 2 nM enzyme, 1 mM PRPP, 50 mM Tris-HCl, 100 mM KCl and 10 mM MgCl 2 at pH 7.8 and 298 K. The reaction products were analyzed by ion-pair reversephase chromatography using a CAPCELL PAK C18 column (Shiseido Fine Chemicals, Tokyo, Japan) on an Ä KTA system (GE Healthcare, UK). The column was equilibrated with buffer containing 50 mM sodium phosphate pH 7.0, 5 mM tetra-n-butylammonium hydroxide and 0.25% methanol and eluted with a linear gradient of methanol from 0.25% to 30%. Products and reactants were quantified by measuring their absorbance at 256 and 276 nm. Kinetic constants were determined by fitting the Michaelis-Menten-type equation k app = k cat [S]/([S] +K M ).
In order to confirm the reaction products, an APEX IV 9.4 T FT-ICR mass spectrometer with Apollo electrospray ionization (ESI) source (Bruker, USA) controlled by apexControl v.2.0.0 beta-version software for Windows XP was used. The mass spectrometer was operated in negative mode with 4500 and 4000 V voltages for the capillary and spray shield, respectively. The capillary exit was set to À90 V and the ion-accumulation time and flight time were set to 0.5 and 0.0018 s, respectively. All other parameters were optimized by a standard tuning procedure using ES Tuning Mix (Agilent Technologies, USA) under negative mode and calibrated by 1.0 p.p.m. error tolerance. An Ä KTA Explorer system (GE Healthcare, UK) was used to separate the reaction products and confirm each retention time with a flow rate of 25 ml min À1 using a CAPCELL PAK C18 column with a resin diameter of 3 mm, an inner diameter of 1.0 mm and a column length of 75 mm (Shiseido, Tokyo, Japan) and a binary gradient which consisted of the following HPLC-gradient solvents: A, 4 mM dibutylammonium formate (DBAF) pH 8.4; B, 4 mM DBAF pH 8.4, 50% acetonitrile. The gradient was as follows: 0-5 min, 5% B linear; 5-55 min, 60% B gradient; 55-60 min, 100% B gradient; 60-80 min, 100% B linear. 5 ml of each reaction mixture was injected manually using a 20 ml syringe (Hamilton, Switzerland) and the nucleoside monophosphate and PRPP standards were analyzed using the same gradient. The total ion chromatogram and the exact molecular weight of each result produced by FT-ICR/MS were further analyzed by DataAnalysis v.3.4 software (Bruker Daltonics, USA). The theoretical ion m/z of each product and the cofactor PRPP were calculated as follows: GMP,
Crystallization, data collection and structure determination
The unliganded TtHGPRTase was crystallized by the hanging-drop vapour-diffusion method. 1 ml protein solution (10.33 mg ml À1 ) was mixed with an equal volume of a reservoir solution consisting of 38% dioxane, 15% glycerol and 18 mM Tris-HCl buffer pH 8.0 and equilibrated against 100 ml reservoir solution at 293 K. Crystals of TtHGPRTase-IMP and TtHGPRTase-GMP were obtained under the same conditions as used for the unliganded enzyme, except for the concentration of dioxane (29 and 26%, respectively) and the presence of ligands (10 mM IMP and 5 mM GMP, respectively). All of the crystals are isomorphous, with space group P6 5 22 and unit-cell parameters a = b = 66.7, c = 152.6 Å for the apoenzyme, a = b = 67.3, c = 152.2 Å for the IMP complex and a = b = 67.1, c = 152.5 Å for the GMP complex. There is one monomer in the asymmetric unit and $49% of the crystal volume is occupied by solvent. The reaction catalyzed by HGPRTase.
Diffraction data sets were collected at 100 K using a wavelength of 1.0000 Å on the RIKEN Structural Genomics Beamline II (BL26B2; Ueno et al., 2006) at SPring-8 (Hyogo, Japan). All crystals were mounted on nylon loops and flash-cooled to 100 K in an N 2 -gas stream. The crystals were then handled using the SPring-8 Precise Automatic Cryo-sample Exchanger (SPACE), which was controlled using the beamline-scheduling software BSS (Ueno et al., 2004 (Ueno et al., , 2005 . All data were processed using the HKL-2000 program package (Otwinowski & Minor, 1997 ; Table 1 ).
The structure of TtHGPRTase was solved by the molecularreplacement method using AMoRe (Navaza, 1994) with the T. tengcongensis structure (PDB code 1yfz; sequence identity 49%; Chen et al., 2005 ) as a search model. The program CNS (Brü nger et al., 1998) was used for refinement cycles. After each round of refinement, the model was refitted to the OMIT electron-density map by the program XtalView (McRee, 1999) . Water molecules were picked up from the difference maps on the basis of peak-height and distance criteria (Morris et al., 2002) . The same refinement procedure was applied to TtHGPRTase-IMP and TtHGPRTase-GMP but using the coordinates of the unliganded enzyme as the initial model. The quality of the models was validated with PROCHECK (Laskowski et al., 1993) . Refinement statistics are shown in Table 1 . Structure diagrams were drawn using the program PyMOL (DeLano, 2002) .
The atomic coordinates and structure factors for the unliganded enzyme, IMP complex and GMP complex have been deposited in the RCSB Protein Data Bank as entries 3acb, 3acd and 3acc, respectively.
Results and discussion
Enzymatic activity
From the HPLC and mass-spectrometric analyses, the TTHA0220 protein showed phosphoribosyltransferase activity towards hypoxanthine and guanine but not xanthine. Thus, it was confirmed that the TTHA0220 protein is an HGPRTase. The kinetic constants for hypoxanthine were k cat = 9.1 AE 0.8 s À1 and K M = 3.9 AE 1.5 mM and those for guanine were k cat = 18 AE 1 s À1 and K M = 7.4 AE 1.7 mM at pH 7.8 and 298 K. The values for PRPP were k cat = 20 AE 2 s À1 and K M = 68 AE 18 mM determined in the presence of 100 mM guanine. These values are consistent with those for T. gondii HGPRTase (Hé roux, White, Ross, Davis et al., 1999) . These values are also consistent with those for human HGPRTase, except for the K M values for guanine and hypoxanthine (Xu & Grubmeyer, 1998) ; those for TtHGPRTase are ten times higher than those for the human enzyme. Furthermore, these values are also similar to those for other 6oxopurine PRTases such as T. cruzi hypoxanthine PRTase (Canyuk et al., 2004) as well as P. falciparum and T. foetus hypoxanthineguanine-xanthine PRTases (Subbayya & Balaram, 2002; Munagala et al., 1998) .
Overall structure
The overall and subunit structures of TtHGPRTase-IMP are shown with secondary-structure assignment by the program DSSP (Kabsch & Sander, 1983) in Figs. 2(a) and 2(b), respectively. TtHGPRTase consists of 181 amino-acid residues with a molecular mass of 20 173 Da based on the primary structure. The enzyme consists of a hood domain (N-terminus to Ile14 and Asp153 to C-terminus) and a core domain (Ser15-Glu152). The hood domain contains a two-stranded -sheet (-strands b6 and b7) and loop IV, which is characterized by three hydrogen-bonded turns (Kabsch & Sander, 1983; Fig. 2b ). The core domain has an / structure similar to the Rossmann fold, in which a five-stranded parallel -sheet (-strands b2, b1, b3, b4 and b5) is covered by three -helices (a1, a2 and a3) and a 3 10 -helix (a4). Loop II between b2 and b3 is largely disordered as observed in the unliganded forms and 6-oxopurine monophosphate complexes from other species (Schumacher et al., 1996; Somoza et al., 1996; Shi, Li, Tyler, Furneaux, Cahill et al., 1999; Hé roux et al., 2000; Guddat et al., 2002; Keough et al., 2005) .
There is one subunit in the asymmetric unit and the polypeptide chain is folded into a dimeric form with a crystallographic twofold axis. The accessible surface area (ASA) of the subunit interface was calculated to be 2876 Å 2 , meaning that a surface area equivalent to 18.4% of one subunit is buried upon dimerization. The subunit interface is formed by residues from loop I, a2, b2, the C-terminal region of loop II and loop IV. Subunit-subunit interactions are predominantly hydrophobic, with two salt bridges and four neutral hydrogen bonds. Loop I, loop II and loop IV are not only involved in the formation of the subunit interface but also in the formation of the active site. Therefore, dimerization of the enzyme might be essential for enzyme function, although all of the active-site residues which directly interact with the substrates are from one subunit (Subbayya & Balaram, 2002; Canyuk et al., 2004) .
The corresponding C atoms of TtHGPRTase-IMP and TtHGPRTase-GMP superimpose with an r.m.s.d. of 0.15 Å , indicating that the overall folds of these complexes are quite similar to each other. The unliganded form and TtHGPRTase-IMP superimpose less well, with an r.m.s.d. of 0.34 Å (Fig. 2c) displacements of C atoms are found for Asp106 (0.99 Å ), Arg137 (0.72 Å ), Tyr155 (1.13 Å ), Pro178 (0.96 Å ) and Glu179 (0.97 Å ). The binding of IMP to the active site induces movement of the main-chain atoms of Ala154, Tyr155 and Val156 towards IMP, resulting in the formation of hydrogen bonds between the main-chain C O and NH groups of Val156 and the N1-H and C6 O groups of the IMP purine ring and the stacking of the side-chain phenyl ring of Tyr155 on the purine ring ( Figs. 2c and 2d ; Chen et al., 2005) . This movement is accompanied by a shift of the main-chain atoms of the residues Pro178 and Glu179 which are adjacent to residues 154-156. Asp106 is considered to act as a catalytic base to abstract a proton from N7-H of the purine ring (Xu & Grubmeyer, 1998) . The catalytic Asp106, which is hydrogen bonded to the active-site water molecule in the unliganded form, changes its direction towards the solvent side and makes a salt bridge with Arg137 in the TtHGPRTase-IMP complex. This occurs in order to avoid an unusually short contact between the carboxylate of Asp106 and the unprotonated N7 of the purine ring. It is reasonably assumed that the substrate hypoxanthine or guanine is bound to the active site with the protonated N7 involved in the hydrogen bond to Asp106. The change from the attractive interaction between N7 and Asp106 in the enzyme-substrate complex to the repulsive interaction in the enzyme-product complex may assist in product (IMP or GMP) release from the active site.
Active-site structure
The active-site structure is shown in Fig. 2(d) . IMP resides in the pocket formed at the topological switch point between the C-terminal sides of -strands b1 and b3. The active-site cavity is encircled by Asn46, Tyr73, Glu102, Asp103, Asp106, Thr107, Gly108, Thr110, Lys134, Tyr155, Val156, Asp162 and Arg168, the side chains of which interact with the substrates. Tyr73, which belongs to loop II, is disordered in the apo and IMP-bound forms. The purine, ribose and phosphate moieties of IMP occupy positions similar to the corresponding positions of 6-oxopurine analogues and PRPPs in enzymesubstrate complex models (Eads et al., 1994; Somoza et al., 1996; Hé roux et al., 2000; Guddat et al., 2002; Chen et al., 2005) . The hydrogen-bond interactions between the active-site residues and IMP thus mimic enzyme-substrate interactions. The main-chain C O and NH of Val156 form hydrogen bonds to N1-H and C6 O of the IMP purine ring as described above. Lys134 interacts with C6 O and N7 of the purine ring. The side-chain carboxylates of Glu102 and Asp103 form hydrogen bonds to O3 0 and O2 0 of the ribose ring, respectively. Loop III specifically interacts with the phosphate group of IMP. The main chain C O and NH groups of Asp106, Thr107 and Thr110 and the side-chain OH of Thr107 and Thr110 are hydrogen bonded to phosphate O atoms. Water molecules W1-W4 occupy the pyrophosphate-binding site for PRPP Balendiran et al., 1999; Shi, Li, Tyler, Furneaux, Cahill et al., 1999; Hé roux et al., 2000; Canyuk et al., 2001 Canyuk et al., , 2004 .
Structural comparison of 6-oxopurine PRTases
The program SSM (Secondary Structure Matching; Krissinel & Henrick, 2004 ) was used to search the Protein Data Bank for 6-oxopurine PRTase proteins that possess three-dimensional structures similar to that of TtHGPRTase. The highest Q-scores were calculated to be 0.80 for Salmonella typhimurium 6-oxopurine PRTase (44% sequence identity; PDB code 1j7j; C. C. Lee, P. J. Focia, G. Spraggon & A. E. Eakin, unpublished work), 0.79 for that from E. coli (44% sequence identity; PDB code 1g9t; Guddat et al., 2002) , 0.78 for that from T. foetus (42% sequence identity; PDB code 1hgx; Somoza et al., 1996) , 0.76 for that from T. tengcongensis (50% sequence identity; PDB code 1yfz; Chen et al., 2005) , 0.72 for that from L. tarentolae (39% sequence identity; PDB code 1pzm; Monzani et al., 2007) , 0.70 for that from T. cruzi (43% sequence identity; PDB code 1tc1; Focia, Craig, Nieves-Alicea et al., 1998) , 0.54 for that from H. sapiens (36% sequence identity; PDB code 1bzy; and 0.53 for that from T. gondii (30% sequence identity; PDB code 1qk4; Hé roux, White, . The C atoms of TtHGPRTase were superposed on the corresponding atoms of these enzymes with average and maximum r.m.s.d.s of 1.05 and 1.22 Å , respectively, indicating that the overall fold of TtHGPRTase is similar to those of 6-oxopurine PRTases determined to date by X-ray methods (Fig. 3) . Importantly, the active-site structures of 6-oxopurine PRTases have quite a similar structure, guaranteeing the phosphoribosyltransferase activity of these enzymes. The SSM result shows that these enzymes can be tentatively divided into groups I (the first six enzymes plus TtHGPRTase; Fig. 3a ) and II (last two enzymes; Fig. 3b ) on the basis of Q-scores. The gap in Q-scores between groups I and II is at least partly a consequence of the fact that the group II enzymes have an N-terminal extension with additional secondary elements and a long loop connecting -helix a2 and -strand b2 compared with the group I enzymes.
TtHGPRTase is folded into a functional dimer in the group I enzymes from T. foetus, T. cruzi and L. tarentolae. In contrast, in the group I enzymes from S. typhimurium, E. coli and T. tengcongensis and the group II enzymes from H. sapiens and T. gondii two functional dimers associate to form the tetramer. The tetramer interfaces of H. sapiens and T. gondii 6-oxopurine PRTases (the group II enzymes) are predominantly formed by the N-terminal extension and the subsequent -helix a1. In T. tengcongensis, S. typhimurium and E. coli (the group I enzymes), loop II containing the region between -strands b2 and b3 and -helix a3 forms the tetramer interface. Tetramer interfaces are not involved in the formation of the active site in either the group I or II enzymes. These results imply that the dimers common to 6-oxopurine PRTases are essential for catalytic activity and the tetramer is considered to be a dimer of functional dimers.
Of the 13 active-site residues in TtHGPRTase, Lys134, Asp106, Thr107, Thr110, Tyr73, Glu102, Asp103, Asp162 and Arg168 are completely conserved among the 6-oxopurine PRTase structures determined to date by X-ray methods, although Thr107 is replaced by Ser in some cases (Fig. 2d) . The side chains of these residues are involved in interactions with the substrates. The remaining three residues (Gly108, Val156 and Asn46), the main chains of which are hydrogen bonded to the substrates, are Gly or Ala, Val or Ile and a hydrophilic or a positively charged residue, respectively. The overall folds and the active-site structures of 6-oxopurine PRTases are similar for both unliganded forms and product-complex models, although the binding of IMP or GMP induces a small conformational change and the binding of substrate analogues containing pyrophosphate further induces a movement of loop II to encapsulate the substrates from the solvent region (Somoza et al., 1996; Focia, Craig, Nieves-Alicea et al., 1998; Hé roux et al., 2000; Guddat et al., 2002; Canyuk et al., 2004; Chen et al., 2005) . The cis-peptide bond in loop I, Leu45-Asn46, is a common feature of the phosphoribosyltransferare family (Canyuk et al., 2004) and this conformation is also not affected by the ligand binding.
The ribose 5 0 -phosphate moiety of IMP is bound to T. tengcongensis HGPRTase in an unusual position that differs from the common binding site in other 6-oxopurine PRTase complexes with IMP (Chen et al., 2005) . The 2-OH and 3-OH groups of the ribose in T. tengcongensis HGPRTase are directed towards the solvent region and the 5-phosphate occupies the binding site for the pyrophosphate of PRPP (Fig. 3a) . IMP trapped in the unusual position was modelled into the active site of TtHGPRTase by superimposing T. tengcongensis HGPRTase onto TtHGPRTase. The modelled IMP could be bound to TtHGPRTase without any clashes with the protein residues surrounding the active site and its phosphate group interacted with the side chains of Arg168 (Arg167 in T. tengcongensis HGPRTase) and the main-chain NH groups of Gly47 (Gly46) and Asn46 (Lys45), just like IMP in T. tengcongensis HGPRTase. It is possible that two binding sites are available for product release and feedback inhibition as pointed out by Chen et al. (2005) . In T. tengcongensis HGPRTase the common binding site for the IMP phosphate in 6-oxopurine PRTases is partially occupied by acetate derived from the buffer solution. This might be the reason why IMP in T. tengcongensis HGPRTase selects the unusual pyrophosphate-binding (or feedback) position from the two available sites.
In conclusion, although many crystal structures of HGPRTase as well as of related enzymes have been determined, a set of high-resolution structures of TtHGPRTase in the apo, IMP-bound and GMP-bound forms add novel information about the structure and function of the phosphoribosyltransferase. Further analysis of this enzyme family, including that of adenine phosphoribosyltransferase from T. thermophilus, is in progress.
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